Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in Males
Open Access
- 31 December 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (6), 586-592
- https://doi.org/10.1006/mthe.2001.0491
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Direct Exposure of Mouse Spermatogenic Cells to High Doses of Adenovirus Gene Therapy Vector Does Not Result in Germ Cell TransductionHuman Gene Therapy, 2000
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- FDA comments on phase I clinical trials without vector biodistribution dataNature Genetics, 1999
- Gene therapy and the germlineNature Medicine, 1999
- In Vivo Gene Transfer to Mouse Spermatogenic Cells by Deoxyribonucleic Acid Injection into Seminiferous Tubules and Subsequent Electroporation1Biology of Reproduction, 1998
- Germline alteration by gene therapy: assessing and reducing the risksMolecular Medicine Today, 1998
- Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in miceGene, 1997
- Developmentally Regulated Expression of a Mouse Germ Cell Nuclear Antigen Examined from Embryonic Day 11 to Adult in Male and Female MiceDevelopmental Biology, 1994
- No simple solution for making transgenic miceCell, 1989
- High frequency germline acquisition of ecotropic MuLV proviruses in SWR/J-RF/J hybrid miceCell, 1985